Loading…
VEGF121b, a new member of the VEGFxxxb family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo
Background: The key mediator of new vessel formation in cancer and other diseases is VEGF-A. VEGF-A exists as alternatively spliced isoforms - the pro-angiogenic VEGF xxx family generated by exon 8 proximal splicing, and a sister family, termed VEGF xxx b, exemplified by VEGF 165 b, generated by dis...
Saved in:
Published in: | British journal of cancer 2009-10, Vol.101 (7), p.1183-1193 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background:
The key mediator of new vessel formation in cancer and other diseases is VEGF-A. VEGF-A exists as alternatively spliced isoforms - the pro-angiogenic VEGF
xxx
family generated by exon 8 proximal splicing, and a sister family, termed VEGF
xxx
b, exemplified by VEGF
165
b, generated by distal splicing of exon 8. However, it is unknown whether this anti-angiogenic property of VEGF
165
b is a general property of the VEGF
xxx
b family of isoforms.
Methods:
The mRNA and protein expression of VEGF
121
b was studied in human tissue. The effect of VEGF
121
b was analysed by saturation binding to VEGF receptors, endothelial migration, apoptosis, xenograft tumour growth, pre-retinal neovascularisation and imaging of biodistribution in tumour-bearing mice with radioactive VEGF
121
b.
Results:
The existence of VEGF
121
b was confirmed in normal human tissues. VEGF
121
b binds both VEGF receptors with similar affinity as other VEGF isoforms, but inhibits endothelial cell migration and is cytoprotective to endothelial cells through VEGFR-2 activation. Administration of VEGF
121
b normalised retinal vasculature by reducing both angiogenesis and ischaemia. VEGF
121
b reduced the growth of xenografted human colon tumours in association with reduced microvascular density, and an intravenous bolus of VEGF
121
b is taken up into colon tumour xenografts.
Conclusion:
Here we identify a second member of the family, VEGF
121
b, with similar properties to those of VEGF
165
b, and underline the importance of the six amino acids of exon 8b in the anti-angiogenic activity of the VEGF
xxx
b isoforms. |
---|---|
ISSN: | 0007-0920 1532-1827 |
DOI: | 10.1038/sj.bjc.6605249 |